The Analysts Set $27.00 Price Target for Crispr Therapeutics AG (CRSP) – Normangee Star
Normangee Star |
The Analysts Set $27.00 Price Target for Crispr Therapeutics AG (CRSP)
Normangee Star Chardan Capital initiated coverage on shares of Crispr Therapeutics AG in a research report on Monday. After $-0.31 actual EPS reported by Intellia Therapeutics Inc for the previous quarter, Wall Street now forecasts -16.13% EPS growth. Piper Jaffray … |
